Biowatch Friends ApS - CVR: 42335088

2023, DKK

20.06.2024

Bruttoresultat

-4.027

Primær drift

-3.819'

Årets resultat

-3.818'

Aktiver

4.282'

Kortfristede aktiver

36.390

Egenkapital

-3.783'

Afkastningsgrad

-89 %

Soliditetsgrad

-88 %

Likviditetsgrad

+500%

Resultat

20.06.2024

Årsrapport	2023 20.06.2024	2022 16.06.2023	2021 18.01.2022
Nettoomsætning
Bruttoresultat	-4.027	-2.752	-3.330
Resultat af primær drift	-3.818.807	0	0
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0
Finansielle indtægter	0	0	0
Finansieringsomkostninger	0	-294	-459
Andre finansielle omkostninger	0	0	0
Resultat før skat	-3.818.807	-3.046	-3.789
Resultat	-3.817.921	-2.376	-2.955
Forslag til udbytte	0	0	0

Aktiver

20.06.2024

Årsrapport	2023 20.06.2024	2022 16.06.2023	2021 18.01.2022
Kortfristede varebeholdninger	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	2.390	1.504	834
Likvider	34.000	35.165	37.461
Kortfristede aktiver	36.390	36.669	38.295
Immaterielle aktiver og goodwill	0	0	0
Finansielle anlægsaktiver	4.245.220	8.060.000	5.560.000
Materielle aktiver	0	0	0
Langfristede aktiver	4.245.220	8.060.000	5.560.000
Aktiver	4.281.610	8.096.669	5.598.295

Aktiver

20.06.2024

Passiver

20.06.2024

Årsrapport	2023 20.06.2024	2022 16.06.2023	2021 18.01.2022
Forslag til udbytte	0	0	0
Egenkapital	-3.783.251	34.669	37.045
Hensatte forpligtelser	0	0	0
Langfristet gæld til banker	0	0	0
Anden langfristet gæld			0
Leverandører af varer og tjenesteydelser	2.000	2.000	1.250
Kortfristede forpligtelser	2.861	2.000	1.250
Gældsforpligtelser	8.064.861	8.062.000	5.561.250
Forpligtelser	8.064.861	8.062.000	5.561.250
Passiver	4.281.610	8.096.669	5.598.295

Passiver

20.06.2024

Nøgletal

20.06.2024

Årsrapport	2023 20.06.2024	2022 16.06.2023	2021 18.01.2022
Afkastningsgrad	-89,2 %	Na.	Na.
Dækningsgrad	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.
Egenkapitals-forretning	100,9 %	-6,9 %	-8,0 %
Payout-ratio	Na.	Na.	Na.
Gældsdæknings-nøgletal	Na.	Na.	Na.
Soliditestgrad	-88,4 %	0,4 %	0,7 %
Likviditetsgrad	1.271,9 %	1.833,5 %	3.063,6 %

Resultat

20.06.2024

Gæld

20.06.2024

Årsrapport

20.06.2024

Nyeste:01.01.2023- 31.12.2023(offentliggjort: 20.06.2024)

Information om virksomhedens regnskabsklasse:The annual report of Biowatch Friends ApS for 2023 has been presented in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B.

Oplysning om pantsætninger og sikkerhedsstillelser:5. Collaterals and securities No securities or mortgages exist at the balance sheet date.

Beretning

20.06.2024

Dato for ledelsens godkendelse af årsrapporten:2024-06-19

Ledelsespåtegning: Today, Management has considered and adopted the Annual Report of Biowatch Friends ApS for the financial year 1 January 2023 - 31 December 2023. The Annual Report is presented in accordance with the Danish Financial Statements Act. In our opinion, the Financial Statements give a true and fair view of the assets, liabilities and financial position of the Company at 31 December 2023 and of the results of the Company's operations for the financial year 1 January 2023 - 31 December 2023. In our opinion, the Management's Review includes a true and fair account of the matters addressed in the review. The conditions for not conducting an audit of the Financial Statement have been met. We recommend that the Annual Report be adopted at the Annual General Meeting. Copehangen, 19 June 2024 Executive Board Svend Tøttrup CEO Supervisory Board Birger Baylund Lau Melchiorsen Formand Medlem

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, Management has considered and adopted the Annual Report of Biowatch Friends ApS for the financial year 1 January 2023 - 31 December 2023.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:The Company's principal activities The Company's principal activities consist in owning shares in and provide loans to Biowatch Holding ApS. Biowatch Friends is an investment syndicate with Baylund Management ApS as lead investor (68,7%) and LTM Consult Holding ApS (31,3%).